Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis.
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
The best clinical paper on multiple sclerosis in 2012: Commentary.
Pediatric multiple sclerosis: pathobiological, clinical, and magnetic resonance imaging features.
Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Neuropsychological Performance, Brain Imaging, and Driving Violations in Multiple Sclerosis.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.
The evolution of vertebrate and invertebrate myelin: a theoretical computational study.
Headache in multiple sclerosis and autoimmune disorders.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
Agent Orange Exposure and Prevalence of Self-reported Diseases in Korean Vietnam Veterans.
Oligoclonal bands in multiple sclerosis patients: worse prognosis?
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Pages
« first
‹ previous
…
498
499
500
501
502
503
504
505
506
…
next ›
last »